Helix BioPharma Appoints Deloitte as Strategic Advisor to Explore Partnering and Licensing Opportunities
Pharmaceutical Investing Helix BioPharma Corp. Announces Licence for Worldwide Right to Anti-CEACAM6 Antibody From the Government of Canada
Helix BioPharma Announces the Signing of a Non-Binding Letter of Intent With ProMab Biotechnologies to Develop Cell Based Therapies
Helix BioPharma Corp. Announces L-DOS47 Immuno-Oncology Scientific Presentation at the Medical University of Warsaw
Bold Ventures Announces Increase and Extension of Non-Brokered Private Placement and Closing of Third Tranche, and Signs Agreement with Investor News Network
Finlay Minerals Announces Non-Brokered Private Placement of Flow-Through Shares and Non-Flow-Through Units
Ramp Metals Announces Closing of Oversubscribed Non-Brokered Private Placement for Proceeds of Approximately $3.425M
